AI platform connecting the full drug development lifecycle from discovery to clinical data analysis, built by ex-Palantir engineers.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Seed Perceptic (London), founded by former Palantir engineers, emerged from stealth with a $12M seed led by Accel for its intelligence layer that follows a drug from discovery to clinical development. | $12M |